Science and research.
Learn about our grants and research projects.
Our research.
We fund world-class, animal-free scientific research into how environmental chemicals such as Endocrine Disrupting Chemicals (EDCs) contribute to breast cancer risk.. Our work helps to strengthen scientific understanding, inform policy, and empower more people to take action to reduce their risk of breast cancer.
Your donations and vital support enable us to fund pioneering research that uncovers the causes of breast cancer. We collaborate with leading scientists to explore how environmental and chemical risk factors may increase breast cancer risk.
Why this research matters.
- Our findings are already shaping policy. For example, research from one of our completed projects served as key evidence in the 2021 passing of a New York State Senate Bill that bans several bisphenols from children’s products.
- Real-world exposure: We are shifting our research to study combined, low-dose chemical mixtures, not single chemicals in isolation. This approach is more human-relevant because it mirrors how people are actually exposed to chemicals in daily life.
- Mechanistic insight and better models: We use advanced laboratory models to get a deeper, more accurate understanding of what happens inside the human body. These methods, including patient-derived tissue models, 3D spheroids, and organ-on-a-chip technology, improve the translation of our findings from the lab to patients, all while avoiding the use of animals.
Looking for a grant?
Our current grant round (2025/26) is now open!. Breast Cancer UK has chosen to focus on the relationship between environmental chemicals and breast cancer risk as it has been identified as an area of unmet need in breast cancer research.
We have two funding streams available. Deadline for applications is the 12th February 2026.
Discover more about our groundbreaking animal-free research.
Decades of scientific evidence inform our concern about the link between harmful chemicals and breast cancer. We leverage this growing body of proof, collaborating with global partners, to drive our work.
See the vital research we're currently funding.